卒中伴阻塞性睡眠呼吸暂停综合征的生物学标志物研究进展

doi:10.3969/j.issn.1673-5765.2023.05.004

摘要/Abstract

摘要： 阻塞性睡眠呼吸暂停综合征（obstructive sleep apnea syndrome，OSAS）是最常见的慢性疾病之一，也是导致发生卒中、卒中后功能恢复不良及卒中再发的独立危险因素。60%～70%的卒中患者在急性期出现睡眠呼吸暂停，其中以OSAS最常见。目前多导睡眠监测是OSAS诊断的“金标准”，但其操作过程烦琐，需要大量的医务人员，检查费用较高，易致OSAS患者诊疗延迟。目前已经研发出一些OSAS的院外筛查设备，但其准确性仍有待提高。因此，寻求一种操作简便、快捷有效的诊断方法，定期筛查潜在OSAS患者仍具有重要的临床意义。目前OSAS血清诊断标志物筛查可能成为一个理想的筛查OSAS的方法并为预测卒中预后提供参考依据。本文对OSAS在卒中发病病理生理机制中生物标志物的研究进展进行综述，希望有助于指导卒中伴OSAS的诊断、治疗、预防和预后。

文章导读： 本文重点阐述阻塞性睡眠呼吸暂停综合征导致卒中的病理生理机制中的生物标志物，为卒中合并阻塞性睡眠呼吸暂停综合征的筛查提供了研究方向。

关键词: 卒中; 阻塞性睡眠呼吸暂停综合征; 生物标志物

Abstract: Obstructive sleep apnea syndrome (OSAS) is one of the most common chronic disorders, with an independent risk factor for stroke, poor recovery after stroke, and recurrent stroke. 60%-70% of patients with stroke have sleep apnea in the acute stage, of which OSAS is the most common. The current diagnostic criteria for OSAS is polysomnography, but the operation process is cumbersome, requires a large number of medical staff, and the examination is expensive, which delays the diagnosis and treatment of OSAS. Some out-of-hospital screening devices for OSAS have been developed, but their accuracy needs to be improved. Therefore, it is of great significance to find a simple, fast and effective diagnostic method and regularly screen potential OSAS. At present, biomarkers of OSAS may become an ideal method for screening OSAS and provide a reference for predicting stroke prognosis. This paper reviews the research progress of biomarkers of OSAS in the pathogenesis and physiology of stroke, hoping to help clinicians improve the diagnosis, treatment, disease prevention and prognosis of patients with stroke with OSAS.

Key words: Stroke; Obstructive sleep apnea syndrome; Biomarkers

黄真灿, 张亚男, 孙晴晴, 吴小丹, 王赞. 卒中伴阻塞性睡眠呼吸暂停综合征的生物学标志物研究进展[J]. 中国卒中杂志, 2023, 18(05): 514-519.

HUANG Zhencan, ZHANG Ya’nan, SUN Qingqing, WU Xiaodan, WANG Zan.

Study of Biomarkers of Stroke with Obstructive Sleep Apnea Syndrome

[J]. Chinese Journal of Stroke, 2023, 18(05): 514-519.

参考文献

[1] ANDRÉ S，ANDREOZZI F，VAN OVERSTRAETEN C，et al. Cardiometabolic comorbidities in obstructive sleep apnea patients are related to disease severity，nocturnal hypoxemia，and decreased sleep quality[J/OL]. Respir Res，2020，21（1）：35[2023-04-02]. https://doi.org/10.1186/s12931-020-1284-7.
[2] DYKEN M E，IM K B. Obstructive sleep apnea and stroke[J]. Chest，2009，136（6）：1668-1677.
[3] GUILLEMINAULT C，TILKIAN A，DEMENT W C. The sleep apnea syndromes[J/OL]. Annu Rev Med，1976，27：465-484[2023-04-02]. https://doi.org/10.1146/annurev.me.27.020176.002341.
[4] IP M S，LAM B，CHAN L Y，et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure[J]. Am J Respir Crit Care Med，2000，162（6）：2166-2171.
[5] RYAN S，TAYLOR C T，MCNICHOLAS W T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome[J]. Circulation，2005，112（17）：2660-2667.
[6] JURADO-GAMEZ B，GOMEZ-CHAPARRO J L，MUÑOZ-CALERO M，et al. Serum proteomic changes in adults with obstructive sleep apnoea[J]. J Sleep Res，2012，21（2）：139-146.
[7] WALLDIUS G，JUNGNER I. Apolipoprotein B and apolipoprotein A-I：risk indicators of coronary heart disease and targets for lipid-modifying therapy[J]. J Intern Med，2004，255（2）：188-205.
[8] XU H J，GUAN J，YI H L，et al. Elevated low-density lipoprotein cholesterol is independently associated with obstructive sleep apnea：evidence from a large-scale cross-sectional study[J]. Sleep Breath，2016，20（2）：627-634.
[9] CAO B，FAN Z Q，ZHANG Y H，et al. Independent association of severity of obstructive sleep apnea with lipid metabolism of atherogenic index of plasma（AIP）and apoB/apoAI ratio[J]. Sleep Breath，2020，24（4）：1507-1513.
[10] HELLMAN N E，GITLIN J D. Ceruloplasmin metabolism and function[J/OL]. Annu Rev Nutr，2002，22：439-458[2023-04-02]. https://doi.org/10.1146/annurev.nutr.22.012502.114457.
[11] VAIDYA S M，KAMALAKAR P L. Copper and ceruloplasmin levels in serum of women with breast cancer[J]. Indian J Med Sci，1998，52（5）：184-187.
[12] LAVIE L，LAVIE P. Smoking interacts with sleep apnea to increase cardiovascular risk[J]. Sleep Med，2008，9（3）：247-253.
[13] COX C，TEKNOS T N，BARRIOS M，et al. The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma[J/OL]. Laryngoscope，2001，111（4 Pt 1）：696-701[2023-04-02]. https://doi.org/10.1097/00005537-200104000-00024.
[14] OZCELIK F，ERDOGAN O，AKTOZ M，et al. Diagnostic value of plasma fibronectin level in predicting the presence and severity of coronary artery disease[J]. Ann Hematol，2009，88（3）：249-253.
[15] OREM C，DURMUŞ I，KILINÇ K，et al. Plasma fibronectin level and its association with coronary artery disease and carotid intima-media thickness[J]. Coron Artery Dis，2003，14（3）：219-224.
[16] STENMAN S，VON SMITTEN K，VAHERI A. Fibronectin and atherosclerosis[J/OL]. Acta Med Scand Suppl，1980，642：165-170[2023-04-02]. https://doi.org/10.1111/j.0954-6820.1980.tb10949.x.
[17] ZHANG H N，YANG F，GUO Y C，et al. The contribution of chronic intermittent hypoxia to OSAHS：from the perspective of serum extracellular microvesicle proteins[J/OL]. Metabolism，2018，85：97-108[2023-04-02]. https://doi.org/10.1016/j.metabol.2018.02.012.
[18] ZHANG Y N，WU X D，SUN Q Q，et al. Biomarkers and dynamic cerebral autoregulation of obstructive sleep apnea-hypopnea syndrome[J/OL]. Nat Sci Sleep，2021，13：2019-2028[2023-04-02]. https://doi.org/10.2147/NSS.S328348.
[19] HOPPS E，CANINO B，MONTANA M，et al. Gelatinases and their tissue inhibitors in a group of subjects with obstructive sleep apnea syndrome[J]. Clin Hemorheol Microcirc，2016，62（1）：27-34.
[20] 沈恺妮，李剑. 原发性轻链型淀粉样变的治疗进展[J]. 中国实验血液学杂志，2015，23（3）：910-914.
[21] HARRIS-TRYON T A，GRICE E A. Microbiota and maintenance of skin barrier function[J]. Science，2022，376（6596）：940-945.
[22] JURADO-GÁMEZ B，FERNANDEZ-MARIN M C，GÓMEZ-CHAPARRO J L，et al. Relationship of oxidative stress and endothelial dysfunction in sleep apnoea[J]. Eur Respir J，2011，37（4）：873-879.
[23] 温伟生，胡敏，柳春明，等. 不同体位下软腭位置与腭后气道的相关性研究[J]. 军医进修学院学报，2001，22（1）：57-59.
[24] 杨怀安，刘艾竹，李赛楠，等. 不同程度OSAHS患者腭咽软组织病理形态学改变[J]. 临床耳鼻咽喉头颈外科杂志，2012，26（24）：1119-1122，1126.
[25] RYAN S，TAYLOR C T，MCNICHOLAS W T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome[J]. Circulation，2005，112（17）：2660-2667.
[26] MAKINO S，FUJIWARA M，SUZUKAWA K，et al. Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol binding protein-4 level in obstructive sleep apnea syndrome[J]. Horm Metab Res，2009，41（3）：221-226.
[27] PERES B U，ALLEN A J H，KENDZERSKA T，et al. Obstructive sleep apnea severity，body mass index，and circulating levels of cellular adhesion molecules[J]. Lung，2020，198（6）：939-945.
[28] SUN H L，DU Y H，ZHANG L C，et al. Increasing circulating ESM-1 and adhesion molecules are associated with earlystage atherosclerosis in OSA patients：a cross-sectional study[J/OL]. Sleep Med，2022，98：114-120[2023-04-02]. https://doi.org/10.1016/j.sleep.2022.06.015.
[29] TIAN Z S，XIAO J Y，KANG J，et al. Effects of continuous positive airway pressure on cell adhesion molecules in patients with obstructive sleep apnea：a meta-analysis[J]. Lung，2021，199（6）：639-651.
[30] BAGAI K，MULDOWNEY J A，SONG Y，et al. Circadian variability of fibrinolytic markers and endothelial function in patients with obstructive sleep apnea[J]. Sleep，2014，37（2）：359-367.
[31] IFERGANE G，OVANYAN A，TOLEDANO R，et al. Obstructive sleep apnea in acute stroke：a role for systemic inflammation[J]. Stroke，2016，47（5）：1207-1212.
[32] BADRAN M，GOZAL D. PAI-1：a major player in the vascular dysfunction in obstructive sleep apnea?[J]. Int J Mol Sci，2022，23（10）：5516[2023-04-02]. https://doi.org/10.3390/ijms23105516.